| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5658429 | Gastroenterology | 2017 | 40 Pages |
Abstract
We identified decreased expression of RNASET2 as a component of TL1A-mediated increase in production of IFNG and as a potential biomarker for patients with severe CD. Further study of the role of RNASET2 in regulating mucosal inflammation may lead to development of novel therapeutic targets.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Rivkah Gonsky, Phillip Fleshner, Richard L. Deem, Eva Biener-Ramanujan, Dalin Li, Alka A. Potdar, Janine Bilsborough, Shaohong Yang, Dermot P.B. McGovern, Stephan R. Targan,